VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
VivoSim Labs, Inc. (VIVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 0 shares for the 3-month period ending 2014-12-31, per its 10-Q filed 2015-02-06.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2015-02-06
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2014-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2013-12-31 was 450.18K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month |
|---|---|---|
| 2014-12-31 | 0.00 shares 10-Q · filed 2015-02-06 | 8.65K shares 10-Q · filed 2015-02-06 |
| 2013-12-31 | 450.18K shares 10-Q · filed 2015-02-06 | 2.49M shares 10-Q · filed 2015-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |